Dr. Hervé Blottière from INRA, Micalis Institute and Metagenopolis, Université Paris-Saclay, France will present his study related to "Human Gut Microbiota : from structure to functions" during the 5th Targeting Microbiota World Congress 2017.
According to...
Read more
Dr. Johannes Espolin Roksund Hov, from Oslo University Hospital, Norway will present his study related to "Intestinal microbiota and primary sclerosing cholangitis" during the 5th Targeting Microbiota World Congress 2017.
According to him: "Primary sclerosing cholangitis...
Read more
During the 2nd Symposium on Skin Microbiota, Dr Markus Egert from the Faculty of Medical & Life Sciences (MLS), Institute for Precision Medicine, Furtwangen University, Villingen-Schwenningen, Germany gave a concise overview about "More than skin-deep:...
Read more
Dr. Federico Rey, from University of Wisconsin-Madison, USA will present his study related to "Diet-microbe interactions and their impact to cardiometabolic health" during the 5th Targeting Microbiota World Congress 2017.
According to him: "Whole-grains, vegetables and...
Read more
Dr. Knut Rudi from Norwegian University of Life Sciences, Norway will present his study related to "The human infant gut microbiota mobilome " during the 5th Targeting Microbiota World Congress 2017.
According to him: "The microbial ecosystem...
Read more
The gut microbiota seem to play a central role in the outcome of patients undergoing allogeneic stem cell transplantation. During the course of allogeneic stem cell transplantation a loss of intestinal microbiota diversity and a...
Read more
Dr. Lorenza Putignani from Bambino Gesù Children's Hospital and Research Institute, Italy will present her study of "Dysbiosis profiling and pediatric diseases: pattern correlations and bacterial dysfuntions." during 5th Targeting Microbiota World Congress 2017.
According to...
Read more
Host genetics modulates the development of metabolic disease and shapes the composition of the gut microbiota. Kreznar, Rey et al. demonstrate that the gut microbiota contributes to strain-specific susceptibility to dietinduced metabolic disease and identify links between microbial metabolism andinsulin secretion.
During Targeting...
Read more
Dr. Ryo Aoki from Ezaki Glico, Tokyo, Japan will present his study of "Probiotics as potential therapeutics in the management of metabolic syndrome" during 5th Targeting Microbiota World Congress 2017.
According to him: "Obesity is becoming...
Read more
Dr. Marcin Ufnal from Medical University of Warsaw, Poland, will talk about gut bacteria and the role of the gut-blood barrier during 5th Targeting Microbiota World Congress 2017.
"Gut bacteria produces numerous biologically active molecules...
Read more
The Cleveland Clinic is building a new Center focused on the microbiome, its involvement in human health, and its potential as a target for therapeutic interventions. We are seeking highly qualified investigators who use definitive...
Read more
Prof. Peter C. Konturek from Thuringia Clinic Saalfeld, Teaching Hospital of the University of Jena, Germany will present the recent advances on fecal microbiota therapy during Targeting Microbiota World Congress 2017.
Read more
Prof. Rheinallt M. Jones from Emory University School of Medicine, USA will talk about "Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway" during Targeting Microbiota World Congress 2017.
"The next phase of microbiome-related studies must focus on...
Read more
Dr. Jakob Zimmermann, University of Bern, Switzerland will highlight "Novel techniques in microbiota research: From meta-omics to single cells" during Targeting Microbiota World Congress 2017.
According to Dr Jakob Zimmermann: "Recent advances in next generation sequencing have...
Read more
"Changes in gut microbiota can modulate the peripheral and central nervous systems, resulting in altered brain function, and suggesting the existence of a microbiota gut-brain axis. In this presentation I will examine recent examples of...
Read more
Pr François Leulier from the Institute of Functional Genomique at Ecole Nationale Supérieure de Lyon, France will review the current knowledge and their recent work on the interconnection between malnutrition, intestinal microbiota, juvenile growth and...
Read more
Numerus studies have shown that probiotics have positive effects in bone. The team of Prof. Pacifici and others have reported that probiotics prevent the loss of bone induced by estrogen deficiency. Probiotics prevent the bone...
Read more
Dear Colleagues,
The 4th World Congress of Targeting Microbiota has just taken place and we are already looking at the future. This edition saw more than 350 participants and an increasing year by year interest.
Thanks to...
Read more
On behalf of the members of the scientific committee and the President of ISM, we are pleased to inform you about the strategies for our annual meeting: 5th World Congress on Targeting Microbiota, which will be...
Read more
On behalf of the International Society of Microbiota, we are honoured to announce the new President of the International Society of Microbiota: Pr Lorenzo Drago from the University of Milano, Italy.
-
Pr Drago commented the last...
Read more
The Scientific Committee of the International Society of Microbiota and Targeting Microbiota World Congress 2017 invites all scientists, academics and industrials to present their researches in microbiota area during the 5th World Congress on Targeting...
Read more
Deadline for Oral Presentations: September 12
The Second ISM Symposium on Skin Microbiota: Towards a New Era in Dermocosmetics which held in June 15, 2017 in Paris was a huge success and gathered more than 70 academics, scientists and industrial experts.
The abstracts book of the 4th ISM World Congress on Microbiota is now available. It contains all the abstracts presented as oral and poster presentations.
